-
公开(公告)号：US20230416248A1
公开(公告)日：2023-12-28
申请号：US18252228
申请日：2021-11-10
Applicant: Foghorn Therapeutics Inc.
Inventor： Kevin J. WILSON , Solymar NEGRETTI , Shawn E.R. SCHILLER , Rishi G. VASWANI , David S. HUANG , Johannes H. VOIGT
IPC: C07D471/04 , C07D519/00 , A61P35/00
CPC classification number: C07D471/04 , C07D519/00 , A61P35/00
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
公开(公告)号：US20230121497A1
公开(公告)日：2023-04-20
申请号：US17795929
申请日：2021-01-29
Applicant: Foghorn Therapeutics Inc.
Inventor： Rishi G. VASWANI , David S. HUANG , Kevin J. WILSON , Shawn E.R. SCHILLER , Neville John ANTHONY
IPC: C07D471/04 , C07D403/14 , C07D401/14 , C07D413/14 , C07D403/12 , C07D405/14 , C07D417/14
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
公开(公告)号：US20210038611A1
公开(公告)日：2021-02-11
申请号：US16965822
申请日：2019-01-29
Applicant: Foghorn Therapeutics Inc.
Inventor： Neville John ANTHONY , David Simon MILLAN , Rishi G. VASWANI , Shawn E.R. SCHILLER
IPC: A61K31/541 , A61K31/4409 , C07D417/14 , A61P35/04 , C07D277/46 , C07D417/10 , C07D417/04 , A61K31/4439 , A61K31/427 , A61K31/4709 , A61K31/4425 , A61K31/5377 , A61K31/506 , A61K31/496 , A61K45/06
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
公开(公告)号：US20230365560A1
公开(公告)日：2023-11-16
申请号：US18315526
申请日：2023-05-11
Applicant: Foghorn Therapeutics Inc.
Inventor： Shawn E.R. SCHILLER , Solymar NEGRETTI , David S. HUANG , Kevin J. WILSON , Melek Nihan UCISIK , Richard CALDWELL
IPC: C07D471/04 , A61K45/06 , C07D519/00
CPC classification number: C07D471/04 , A61K45/06 , C07D519/00 , C07B2200/05
Abstract: The present disclosure features compounds of Formula I,
or pharmaceutically acceptable salts thereof, and formulations containing the same. Methods of treating BAF complex-related disorders, such as cancer, are also disclosed.-
公开(公告)号：US20230079819A1
公开(公告)日：2023-03-16
申请号：US17425140
申请日：2020-01-29
Applicant: Foghorn Therapeutics Inc.
Inventor： Rishi G. VASWANI , Neville John ANTHONY , David Simon MILLAN , Shawn E.R. SCHILLER , Kevin J. WILSON , David S. HUANG
IPC: C07D417/14 , A61P35/00 , C07D498/04 , C07D417/12 , C07D487/04 , C07D491/08 , C07D471/04 , C07D491/107 , C07D491/048
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
Patent Agency Ranking
公开(公告)号：US20250066354A1
公开(公告)日：2025-02-27
申请号：US18926578
申请日：2024-10-25
Applicant: Foghorn Therapeutics Inc.
Inventor： Shawn E.R. SCHILLER , Solymar NEGRETTI , David S. HUANG , Kevin J. WILSON , Melek Nihan UCISIK , Richard CALDWELL
IPC: C07D471/04 , A61K45/06 , C07D519/00
Abstract: The present disclosure features compounds of Formula I, or pharmaceutically acceptable salts thereof, and formulations containing the same. Methods of treating BAF complex-related disorders, such as cancer, are also disclosed.
-
公开(公告)号：US20230348452A1
公开(公告)日：2023-11-02
申请号：US17795615
申请日：2021-01-29
Applicant: Foghorn Therapeutics Inc.
Inventor： Matthew NETHERTON , Shawn E.R. SCHILLER , Jing DENG , Neville John ANTHONY , Francois BRUCELLE , Sabine K. RUPPEL , Johannes H. VOIGT
IPC: C07D417/14 , C07D471/10
CPC classification number: C07D417/14 , C07D471/10
Abstract: The present disclosure features compounds and methods useful for the treatment of BAF complex-related disorders.
-
公开(公告)号：US20220119378A1
公开(公告)日：2022-04-21
申请号：US17425041
申请日：2020-01-29
Applicant: Foghorn Therapeutics Inc.
Inventor： Neville John ANTHONY , Rishi G. VASWANI , David Simon MILLAN , Shawn E.R. SCHILLER
IPC: C07D417/14 , A61P35/00 , C07D471/04
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
公开(公告)号：US20230149414A1
公开(公告)日：2023-05-18
申请号：US17795747
申请日：2021-01-29
Applicant: Foghorn Therapeutics Inc.
Inventor： Neville John ANTHONY , Rishi G. VASWANI , David Simon MILLAN , Shawn E.R. SCHILLER , Kevin J. WILSON
IPC: A61K31/5377 , A61K45/06 , C07D277/46 , A61K31/427 , A61K31/4439 , C07D417/10 , A61K31/506 , C07D417/14 , A61K31/444 , A61P35/00
CPC classification number: A61K31/5377 , A61K45/06 , C07D277/46 , A61K31/427 , A61K31/4439 , C07D417/10 , A61K31/506 , C07D417/14 , A61K31/444 , A61P35/00
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
公开(公告)号：US20230145003A1
公开(公告)日：2023-05-11
申请号：US17795778
申请日：2021-01-29
Applicant: Foghorn Therapeutics Inc.
Inventor： Kevin J. WILSON , Shawn E.R. SCHILLER , Solymar NEGRETTI
IPC: C07D471/04 , A61P35/00 , A61P11/00 , C07D405/12 , C07D405/14 , C07D487/10 , C07D401/12 , C07D413/14 , C07D513/04 , C07D519/00 , C07D417/10 , C07D417/14
CPC classification number: C07D471/04 , A61P35/00 , A61P11/00 , C07D405/12 , C07D405/14 , C07D487/10 , C07D401/12 , C07D413/14 , C07D513/04 , C07D519/00 , C07D417/10 , C07D417/14 , C07B2200/05
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
-
-
-
-
-
-
-
-
Search Results
11
records
(took 0.013 seconds)
